|
Company:
|
GUARDANT HEALTH, INC. (GH)
|
|
Form Type:
|
4
|
|
Filing Date:
|
1/13/2021
|
|
CIK:
|
0001576280
|
|
Address:
|
505 PENOBSCOT DR.
|
|
City, State, Zip:
|
REDWOOD CITY, California 94063
|
|
Telephone:
|
855-698-8887
|
|
Fiscal Year:
|
12/31
|
|
|
|
|
|
Last Trade
|
Last Trade:
$144.83
|
Change:
-9.80 (-6.34%)
|
Trade Time:
03:02 PM EST
|
Market Cap:
$14.54B
|
|
|
|
|
|
|
Description of Business
|
|
We are a leading precision oncology company focused on helping conquer cancer
globally through use of our proprietary blood-based tests, vast data sets and
advanced analytics. We believe that the key to conquering cancer is
unprecedented access to its molecular information throughout all stages of the
disease, which we intend to enable by a routine blood draw, or liquid biopsy.
Our Guardant Health Oncology Platform is designed to leverage our capabilities
in technology, clinical development, regulatory and reimbursement to drive
commercial adoption, accelerate drug development, improve patient clinical
outcomes and lower healthcare costs.
|
|
|
|